| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.27849 |
| P8608 | Fatcat ID | release_dppjs2t2irgeziyszoilbdooby |
| P698 | PubMed publication ID | 22987579 |
| P5875 | ResearchGate publication ID | 230871463 |
| P50 | author | Michael Stürzl | Q41520499 |
| Wilhelm Dirks | Q73011398 | ||
| P2093 | author name string | Don Ganem | |
| Dominika Gaus | |||
| Ramona Jochmann | |||
| P2860 | cites work | Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone | Q24315143 |
| Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines | Q27910543 | ||
| Short tandem repeat profiling provides an international reference standard for human cell lines | Q27910569 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. | Q34295801 | ||
| Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. | Q34513991 | ||
| Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | Q34548882 | ||
| Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo | Q35565392 | ||
| Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. | Q37033342 | ||
| Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction | Q39573744 | ||
| Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
| Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma | Q41100256 | ||
| The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line | Q41113939 | ||
| Isolation and Characterization of an Immortal Neoplastic Cell Line (KS Y-1) From AIDS-Associated Kaposi's Sarcoma | Q41327013 | ||
| Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection | Q41746147 | ||
| Cells derived from sporadic and AIDS-related Kaposi's sarcoma reveal identical cytochemical and molecular properties in vitro | Q44328150 | ||
| Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. | Q52833089 | ||
| P4510 | describes a project that uses | KS Y-1 | Q54900488 |
| SLK | Q54954867 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| renal carcinoma | Q18556333 | ||
| cell line | Q21014462 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1954-1958 | |
| P577 | publication date | 2012-10-12 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line | |
| P478 | volume | 132 |
| Q90604563 | 5-Ethynyl-2'-deoxycytidine and 5-ethynyl-2'-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses |
| Q59358832 | A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5 |
| Q38745770 | A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants |
| Q50062340 | A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus. |
| Q38752511 | ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle. |
| Q38798186 | Alteration of STR profiles in ovarian carcinoma cells during primary culture |
| Q64263465 | Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication |
| Q89899078 | Concurrent Control of KSHV Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: A New Prospect to the Therapeutic Potential of Lipoxin A4 |
| Q37547223 | Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus |
| Q30603461 | Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein |
| Q34363927 | Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation |
| Q30668574 | Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes |
| Q36916266 | Hierarchical regulation of the genome: global changes in nucleosome organization potentiate genome response. |
| Q83227124 | IFI16, a nuclear innate immune DNA sensor, mediates epigenetic silencing of herpesvirus genomes by its association with H3K9 methyltransferases SUV39H1 and GLP |
| Q58698525 | IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD |
| Q91604945 | Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation |
| Q34057984 | Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids |
| Q54217632 | Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells. |
| Q34423454 | KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors |
| Q35715397 | Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms |
| Q35834474 | Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling. |
| Q92376588 | Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis |
| Q41876173 | Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. |
| Q33743857 | Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2. |
| Q35641026 | Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis |
| Q40127660 | Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally. |
| Q47547495 | Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies KSHV microRNA targets in endothelial cells |
| Q35571588 | Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells |
| Q37252928 | Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency. |
| Q42711959 | O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis |
| Q26830643 | Oncogenes and RNA splicing of human tumor viruses |
| Q36238539 | RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. |
| Q38449592 | Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis |
| Q40605206 | Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. |
| Q39030014 | Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis. |
| Q52722164 | Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether. |
| Q91422534 | The KSHV portal protein ORF43 is essential for the production of infectious viral particles |
| Q92421759 | The Kaposi's Sarcoma-Associated Herpesvirus Protein ORF42 Is Required for Efficient Virion Production and Expression of Viral Proteins |
| Q92156491 | The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases |
| Q92684202 | The landscape of transcription initiation across latent and lytic KSHV genomes |
| Q92257146 | Transcriptional and post-transcriptional regulation of viral gene expression in the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus |
| Q35641410 | Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation |
| Q38760921 | Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML. |
| Q64914433 | kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi's sarcoma cells. |
| Q36745445 | mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis |
Search more.